Mirum Pharmaceuticals Stock Quote MIRM - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

24.76

Bid

24.74

Ask

24.78

Volume

205,733

24.47 Day's Range 25.62

23.14 52 Week Range 35.56

Market Cap

1.156B

Previous Close

24.80

Open

25.30

Last Trade

24.78

Last Trade Time

15:46:58

Financial Volume

$ 5,129,205

VWAP

24.9314

Average Volume (3m)

482,959

Shares Outstanding

46,614,274

Dividend Yield

PE Ratio

-7.07

Earnings Per Share (EPS)

-3.51

Revenue

186.37M

Net Profit

-163.42M

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Dover, Delaware, USA

Founded

1970

Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was $24.80. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of $ 23.14 to $ 35.56.

Mirum Pharmaceuticals currently has 46,614,274 shares outstanding. The market capitalization of Mirum Pharmaceuticals is $1.16 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.07.

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on May 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

- First quarter 2024 total revenue of $69.2 million, on track to achieve full-year guidance of $310 to $320 million - FDA approval of LIVMARLI for cholestatic pruritus in PFIC patients achieved...

Mirum Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and...

Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC

- Data demonstrate significant benefit across broadest range of genetic PFIC types ever studied - Significant improvements observed across multiple parameters including pruritus, serum bile...

Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report first quarter 2024 financial results on May 8, 2024. Mirum will also host a conference call to discuss the first...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on April 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.1	-4.25367362722	25.86	26.98	24.47	436240	25.12619844	CS
4	0.13	0.527811611855	24.63	26.98	23.14	408323	24.92051043	CS
12	-4.2	-14.5027624309	28.96	30.23	23.14	482959	26.24492175	CS
26	-6.27	-20.2062520142	31.03	35.56	23.14	588057	28.29233777	CS
52	-1.24	-4.76923076923	26	35.56	23.14	554284	28.21302578	CS
156	7.36	42.2988505747	17.4	35.56	12.82	363625	24.93771457	CS
260	11.76	90.4615384615	13	35.56	6.5126	280679	23.5771852	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0